Preclinical CROs Market Analysis and Scope (2024 to 2031)
Preclinical CROs Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 5.52 billion |
Market Size by 2031 | US$ 11.19 billion |
Global CAGR (2023 - 2031) | 9.2% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Service
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Preclinical CROs Market News and Recent Developments
The Preclinical CROs Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for healthcare fraud analytics and strategies:
- QPS, a global contract research organisation headquartered in the US, has opened a second preclinical research facility in Taipei, Taiwan. The 2,793-square-foot facility will facilitate a research expansion into additional toxicology studies and a newly launched capability in pharmacology studies. (Source: Cision US Inc, Press Release, 2022)
Preclinical CROs Market Report Coverage and Deliverables
The “Preclinical CROs Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles